Work

The AKT inhibitor perifosine in biochemically recurrent, hormone-sensitive prostate cancer (HSPC): A phase II California Cancer Consortium trial

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.4642

Authors: K. G. Chee, P. N. Lara, J. Longmate, P. Twardowski, D. I. Quinn, G. Chatta, D. R. Gandara

Institutions: City Of Hope National Medical Center, City of Hope, University of California Davis Medical Center, University of California, Davis

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W196867158

Cites:

Cited by: 8

Related to: 10